BACKGROUND: Practice effects, which are improvements in cognitive test scores due to repeated exposure to testing materials, may provide information about Alzheimer's disease pathology, which could be useful for clinical trials enrichment. OBJECTIVES: The current study sought to add to the limited literature on short-term practice effects on cognitive tests and their relationship to amyloid deposition on neuroimaging. PARTICIPANTS: Twenty-seven, non-demented older adults (9 cognitively intact, 18 with mild cognitive impairment) received amyloid imaging with 18F-Flutemetamol, and two cognitive testing sessions across one week to determine practice effects. RESULTS: A composite measure of 18F-Flutemetamol uptake correlated significantly with all seven cognitive tests scores on the baseline battery (r's = -0.61 - 0.59, all p's<0.05), with higher uptake indicating poorer cognition. Practice effects significantly added to the relationship (above and beyond the baseline associations) with 18F-Flutemetamol uptake on 4 of the 7 cognitive test scores (partial r's = -0.45 - 0.44, p's<0.05), with higher uptake indicating poorer practice effects. The odds ratio of being "amyloid positive" was 13.5 times higher in individuals with low practice effects compared to high practice effects. CONCLUSIONS: Short-term practice effects over one week may be predictive of progressive dementia and serve as an affordable screening tool to enrich samples for preventative clinical trials in Alzheimer's disease.
BACKGROUND: Practice effects, which are improvements in cognitive test scores due to repeated exposure to testing materials, may provide information about Alzheimer's disease pathology, which could be useful for clinical trials enrichment. OBJECTIVES: The current study sought to add to the limited literature on short-term practice effects on cognitive tests and their relationship to amyloid deposition on neuroimaging. PARTICIPANTS: Twenty-seven, non-demented older adults (9 cognitively intact, 18 with mild cognitive impairment) received amyloid imaging with 18F-Flutemetamol, and two cognitive testing sessions across one week to determine practice effects. RESULTS: A composite measure of 18F-Flutemetamol uptake correlated significantly with all seven cognitive tests scores on the baseline battery (r's = -0.61 - 0.59, all p's<0.05), with higher uptake indicating poorer cognition. Practice effects significantly added to the relationship (above and beyond the baseline associations) with 18F-Flutemetamol uptake on 4 of the 7 cognitive test scores (partial r's = -0.45 - 0.44, p's<0.05), with higher uptake indicating poorer practice effects. The odds ratio of being "amyloid positive" was 13.5 times higher in individuals with low practice effects compared to high practice effects. CONCLUSIONS: Short-term practice effects over one week may be predictive of progressive dementia and serve as an affordable screening tool to enrich samples for preventative clinical trials in Alzheimer's disease.
Entities:
Keywords:
Cognition; PET; amyloid deposition; practice effects
Authors: Charles B Malpas; Michael M Saling; Dennis Velakoulis; Patricia Desmond; Terence J O'Brien Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Rik Vandenberghe; Koen Van Laere; Adrian Ivanoiu; Eric Salmon; Christine Bastin; Eric Triau; Steen Hasselbalch; Ian Law; Allan Andersen; Alex Korner; Lennart Minthon; Gaëtan Garraux; Natalie Nelissen; Guy Bormans; Chris Buckley; Rikard Owenius; Lennart Thurfjell; Gill Farrar; David J Brooks Journal: Ann Neurol Date: 2010-09 Impact factor: 10.422
Authors: Kevin Duff; Leigh J Beglinger; Susan K Schultz; David J Moser; Robert J McCaffrey; Richard F Haase; Holly J K Westervelt; Douglas R Langbehn; Jane S Paulsen Journal: Arch Clin Neuropsychol Date: 2006-12-04 Impact factor: 2.813
Authors: Joanna M Fiszdon; Joel F McClough; Steven M Silverstein; Morris D Bell; Justin R Jaramillo; Thomas E Smith Journal: Psychiatry Res Date: 2006-07-24 Impact factor: 3.222
Authors: Kevin Duff; Leigh J Beglinger; David J Moser; Susan K Schultz; Jane S Paulsen Journal: Am J Geriatr Psychiatry Date: 2010-01 Impact factor: 4.105
Authors: Kevin Duff; Kayla R Suhrie; Bonnie C A Dalley; Jeffrey S Anderson; John M Hoffman Journal: Clin Neuropsychol Date: 2018-06-08 Impact factor: 3.535
Authors: Dustin B Hammers; Kayla Suhrie; Ava Dixon; Brian D Gradwohl; Zane G Archibald; Jace B King; Robert J Spencer; Kevin Duff; John M Hoffman Journal: Neuropsychol Dev Cogn B Aging Neuropsychol Cogn Date: 2021-05-05
Authors: Yen Ying Lim; Jenalle E Baker; Andrea Mills; Loren Bruns; Christopher Fowler; Jurgen Fripp; Stephanie R Rainey-Smith; David Ames; Colin L Masters; Paul Maruff Journal: Alzheimers Dement (Amst) Date: 2021-03-16
Authors: Aubryn Samaroo; Rebecca E Amariglio; Samantha Burnham; Paige Sparks; Michael Properzi; Aaron P Schultz; Rachel Buckley; Keith A Johnson; Reisa A Sperling; Dorene M Rentz; Kathryn V Papp Journal: Alzheimers Dement (Amst) Date: 2021-01-05
Authors: Eva C Alden; Emily S Lundt; Erin L Twohy; Teresa J Christianson; Walter K Kremers; Mary M Machulda; Clifford R Jack; David S Knopman; Michelle M Mielke; Ronald C Petersen; Nikki H Stricker Journal: Alzheimers Dement (Amst) Date: 2022-07-15
Authors: Roos J Jutten; Evan Grandoit; Nancy S Foldi; Sietske A M Sikkes; Richard N Jones; Seo-Eun Choi; Melissa L Lamar; Diana K N Louden; Joanne Rich; Douglas Tommet; Paul K Crane; Laura A Rabin Journal: Alzheimers Dement (Amst) Date: 2020-07-09